Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Consult Pharm ; 25(5): 320-2, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20497930

RESUMEN

OBJECTIVE: To present a case of syndrome of inappropriate antidiuretic hormone (SIADH) associated with the use of tolterodine. SETTING: An acute-care unit at a university hospital with a comprehensive program for elders. CASE SUMMARY: In this case report, we present a 99-year-old female who was admitted to our unit for suspected gastrointestinal bleeding who subsequently developed hyponatremia. After the initiation of tolterodine for urinary incontinence, the patient's sodium dropped to 121 mEq/L (from a usual baseline that ranged between 128 mEq/L and 134 mEq/L). Laboratory and urinary findings revealed a serum osmolality of 220 mOsm/kg, a urinary osmolality of 340 mOsm/kg, and a urinary sodium of 101 mmol/L, suggesting a euvolemic hyponatremic state consistent with SIADH. Tolterodine therapy was promptly discontinued, and patient sodium levels normalized. CONCLUSION: Although the etiology of SIADH is often obscure and multifactorial, clinicians should be aware that it is a major cause of hyponatremia among hospitalized elderly patients, and drug therapies must always be evaluated to prevent further complications.


Asunto(s)
Compuestos de Bencidrilo/efectos adversos , Cresoles/efectos adversos , Síndrome de Secreción Inadecuada de ADH/inducido químicamente , Antagonistas Muscarínicos/efectos adversos , Fenilpropanolamina/efectos adversos , Anciano de 80 o más Años , Compuestos de Bencidrilo/uso terapéutico , Cresoles/uso terapéutico , Femenino , Humanos , Hiponatremia/diagnóstico , Hiponatremia/etiología , Síndrome de Secreción Inadecuada de ADH/diagnóstico , Antagonistas Muscarínicos/uso terapéutico , Fenilpropanolamina/uso terapéutico , Tartrato de Tolterodina , Incontinencia Urinaria/tratamiento farmacológico
2.
J Neurosci ; 26(32): 8339-51, 2006 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-16899729

RESUMEN

Activity-dependent regulation of synaptic AMPA receptor (AMPAR) number is critical to NMDA receptor (NMDAR)-dependent synaptic plasticity. Using quantitative high-resolution in situ hybridization, we show that mRNAs encoding the AMPA-type glutamate receptor subunits (GluRs) 1 and 2 are localized to dendrites of hippocampal neurons and are regulated by paradigms that alter synaptic efficacy. A substantial fraction of synaptic sites contain AMPAR mRNA, consistent with strategic positioning and availability for "on-site" protein synthesis. NMDAR activation depletes dendritic levels of AMPAR mRNAs. The decrease in mRNA occurs via rise in intracellular Ca2+, activation of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling, and transcriptional arrest at the level of the nucleus. The decrease in mRNA is accompanied by a long-lasting reduction in synaptic AMPAR number, consistent with reduced synaptic efficacy. In contrast, group I metabotropic GluR signaling promotes microtubule-based trafficking of existing AMPAR mRNAs from the soma to dendrites. Bidirectional regulation of dendritic mRNA abundance represents a potentially powerful means to effect long-lasting changes in synaptic strength.


Asunto(s)
Dendritas/metabolismo , Hipocampo/fisiología , Plasticidad Neuronal/fisiología , Neuronas/fisiología , ARN Mensajero/metabolismo , Receptores AMPA/metabolismo , Transmisión Sináptica/fisiología , Animales , Células Cultivadas , Ratas , Ratas Sprague-Dawley , Distribución Tisular
3.
Diagn Microbiol Infect Dis ; 67(2): 180-4, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20356699

RESUMEN

We undertook a retrospective cohort study describing general outcomes and specific factors associated with positive outcomes in bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP). Forty-eight patients were included, of which 42% died at 30 days. Forty-two percent of patients were in septic shock at the time of the first positive blood culture, and 42% were recipients of solid organ transplants. Lack of microbiologic eradication at 7 days was independently associated with 30-day mortality. Adjunctive procedures performed for source control and microbiologic eradication at 7 days were associated with a favorable clinical response at 7 days. Time to initiation and receipt at any time of antimicrobials with in vitro activity against CRKP were not associated with improved survival. Breakthrough bacteremia occurred in 8 cases, all in patients receiving tigecycline. Our data suggest that severity of illness, rapid microbiologic eradication, and source control are crucial factors in the outcomes of patients with CRKP bacteremia.


Asunto(s)
Antibacterianos/farmacología , Bacteriemia/microbiología , Carbapenémicos/farmacología , Infecciones por Klebsiella/microbiología , Klebsiella pneumoniae/efectos de los fármacos , Resistencia betalactámica , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacteriemia/mortalidad , Bacteriemia/patología , Estudios de Cohortes , Femenino , Humanos , Control de Infecciones/métodos , Infecciones por Klebsiella/tratamiento farmacológico , Infecciones por Klebsiella/mortalidad , Infecciones por Klebsiella/patología , Klebsiella pneumoniae/aislamiento & purificación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Choque Séptico/microbiología , Choque Séptico/mortalidad , Choque Séptico/patología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA